Evidence map›Paper›PMID 29793992›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2018

Thrombotic Regulation From the Endothelial Cell Perspectives.

Miao Wang, Huifeng Hao, Nicholas J Leeper, Liyuan Zhu, Early Career Committee

Abstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Peripheral artery disease.Nature reviews. Disease primers · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miao WangFrom the State Key Laboratory of Cardiovascular Disease (M.W., H.H., L.Z.) miao.wang@pumc.edu.cn.
Huifeng HaoFrom the State Key Laboratory of Cardiovascular Disease (M.W., H.H., L.Z.).
Nicholas J LeeperDivision of Vascular Surgery, Stanford University, CA (N.J.L.).
Liyuan ZhuFrom the State Key Laboratory of Cardiovascular Disease (M.W., H.H., L.Z.).
Early Career Committee

Funding

The paradoxical role of CDKN2B in blood vessel sprouting and maturationR01HL125224 · NHLBI · STANFORD UNIVERSITY · PI LEEPER, NICHOLAS JAMES · 2015 to 2018
$1.9M
The role of CDKN2B in efferocytosis and atherosclerosisR01HL123370 · NHLBI · STANFORD UNIVERSITY · PI LEEPER, NICHOLAS JAMES · 2015 to 2018
$1.6M
NHLBI NIH HHS R01 HL123370NHLBI NIH HHS R01 HL125224
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood CoagulationAnimalsEndothelial CellsHumansPlasminogen Activator Inhibitor 1Protein CSignal TransductionThrombomodulinThromboplastinThrombosisvon Willebrand FactorPlasminogen Activator Inhibitor 1Protein CSERPINE1 protein, humanThrombomodulinThromboplastinvon Willebrand Factorblood plateletsendothelial cellsfibrinthrombosisvon Willebrand factor

Identifiers

PMID29793992
PMCPMC6218174

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.